Garg Ishan, Hanif Hamza, Javed Nismat, Abbas Ramsha, Mirza Samir, Javaid Muhammad Ali, Pal Suman, Shekhar Rahul, Sheikh Abu Baker
Department of Internal Medicine, Maimonides Medical Center, Brooklyn, New York, NY 11219, USA.
Department of General Surgery, University of New Mexico Health Sciences Center, Albuquerque, NM 87106, USA.
Infect Dis Rep. 2021 Oct 7;13(4):872-887. doi: 10.3390/idr13040079.
The coronavirus 2019 (COVID-19) pandemic has disproportionately impacted lesbian, gay, bisexual, transgender, queer (LGBTQ+) people. Despite developing safe and effective COVID-19 vaccines, LGBTQ+ communities still faces challenges due to inequitable access and vaccine hesitancy. Vaccine hesitancy is a delay in the acceptance or refusal of vaccines despite the availability of vaccination services. Various studies have explored and tried to address factors influencing vaccine hesitancy. However, the LGBTQ+ population remains under- and misrepresented in many of these studies. According to the few studies that have focused on the LGBTQ+ population, several factors influencing vaccine hesitancy have been identified, with the most common factors in studies being concern about vaccine safety, vaccine efficacy, and history of bad experiences with healthcare providers. In order to rebuild the confidence of LGBTQ+ people in vaccines, governments, healthcare policymakers, and healthcare providers need to start by acknowledging, and then resolving, these disparities; building trust; dismantling systemic suppression and discrimination; and prioritizing the inclusion of LGBTQ+ people in research studies and public health policies.
2019年冠状病毒病（COVID-19）大流行对女同性恋、男同性恋、双性恋、跨性别、酷儿（LGBTQ+）群体产生了尤为严重的影响。尽管已经研发出了安全有效的COVID-19疫苗，但LGBTQ+群体仍因获得疫苗的机会不平等和对疫苗的犹豫态度而面临挑战。疫苗犹豫是指尽管有疫苗接种服务，但仍延迟接受或拒绝接种疫苗的情况。各种研究已经探讨并试图解决影响疫苗犹豫的因素。然而，LGBTQ+人群在许多此类研究中仍然未得到充分体现且被错误呈现。根据少数针对LGBTQ+人群的研究，已经确定了一些影响疫苗犹豫的因素，研究中最常见的因素是对疫苗安全性、疫苗效力以及与医疗服务提供者的不良经历的担忧。为了重建LGBTQ+人群对疫苗的信心，政府、医疗政策制定者和医疗服务提供者需要首先承认并解决这些差异；建立信任；消除系统性的压制和歧视；并优先将LGBTQ+人群纳入研究和公共卫生政策。
